Etzer Darout

Stock Analyst at BMO Capital

(0.89)
# 2281
Out of 5,386 analysts
128
Total ratings
Success rate
Average return
36 Stocks
Name Action PT Current % Upside Ratings Updated
TERN Terns Pharma
Maintains: Outperform
26 15
3.83 291.64% 5 May 13, 2025
VERV Verve Therapeutics
Maintains: Strong Buy
18 24
11.3 112.39% 2 Apr 15, 2025
IVA Inventiva
Maintains: Buy
12 9
3.05 195.08% 3 Apr 4, 2025
ARVN Arvinas
Maintains: Outperform
82 20
7.53 165.6% 4 Mar 12, 2025
PTGX Protagonist Therapeu...
Reiterates: Outperform
62 72
55.71 29.24% 2 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
130 143
106.77 33.93% 4 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
91 96
52.94 81.34% 6 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
22 3
1.51 98.68% 3 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
21 2
1.13 76.99% 2 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
36 40
43.67 -8.4% 3 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
50
16.55 202.11% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
35
11.64 200.69% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
55
44.15 24.58% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
63
5.47 1051.74% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
28 27
1.21 2131.4% 7 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
132 134
79.64 68.26% 6 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
32 34
8.16 316.67% 5 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
46 48
20.52 133.92% 3 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
118 120
120.33 -0.27% 3 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 38
35.76 6.26% 3 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
26 25
4.74 427.43% 6 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
8 5
1.21 313.22% 9 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
20 20
1.43 1298.6% 3 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
7 6
1.03 482.52% 7 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
4 4
2.27 58.15% 10 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
80 82
69.89 17.33% 4 Apr 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
31
n/a n/a 4 Dec 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 19
4.8 295.83% 2 Apr 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
179 229
n/a n/a 4 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
170
322.64 -47.31% 2 Feb 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
n/a n/a 1 May 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
38
n/a n/a 5 Mar 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
54
56.13 -3.79% 1 Feb 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Sep 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
27 38
51.02 -25.52% 2 Sep 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
54 52
1.45 3486.21% 1 Mar 28, 2018